These results indicate that 50 mg/kg WL mediates remarkable effects on diabetes and related complications by upregulation of AMPK-related hepatic glucose enzyme and lipid metabolism-related gene expression compared to metformin 250 mg/kg. Here, PRKAA2 is linked to diabetes mellitus.